Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 021670/0169 | |
| Pages: | 5 |
| | Recorded: | 10/10/2008 | | |
Attorney Dkt #: | 417451-999054 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
6
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11005440
|
Filing Dt:
|
12/06/2004
|
Publication #:
|
|
Pub Dt:
|
03/15/2007
| | | | |
Title:
|
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11005442
|
Filing Dt:
|
12/06/2004
|
Publication #:
|
|
Pub Dt:
|
02/15/2007
| | | | |
Title:
|
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
|
|
|
Patent #:
|
|
Issue Dt:
|
12/01/2009
|
Application #:
|
11005444
|
Filing Dt:
|
12/06/2004
|
Publication #:
|
|
Pub Dt:
|
03/15/2007
| | | | |
Title:
|
2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11005446
|
Filing Dt:
|
12/06/2004
|
Publication #:
|
|
Pub Dt:
|
03/15/2007
| | | | |
Title:
|
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11005466
|
Filing Dt:
|
12/06/2004
|
Publication #:
|
|
Pub Dt:
|
03/15/2007
| | | | |
Title:
|
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11005472
|
Filing Dt:
|
12/06/2004
|
Publication #:
|
|
Pub Dt:
|
03/15/2007
| | | | |
Title:
|
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
|
|
Assignee
|
|
|
CITTADELLA UNIVERSITARIA SS 554, KM. 4.500 |
MONSERRATO (CA), ITALY 09042 |
|
Correspondence name and address
|
|
MARK KAFKA
|
|
222 EAST 41ST STREET
|
|
JONES DAY
|
|
NEW YORK, NY 10017-6702
|
Search Results as of:
06/07/2024 02:49 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|